The Worldwide Biobanking Industry is Expected to Reach $3.6 Billion by 2027 – Yahoo Finance

Company Logo

Global Biobanking Market

Global Biobanking Market

Dublin, Aug. 12, 2022 (GLOBE NEWSWIRE) -- The "Global Biobanking Market (2022-2027) by Product & Service, Sample, Storage, Application, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

The Global Biobanking Market is estimated to be USD 2.52 Bn in 2022 and is expected to reach USD 3.65 Bn by 2027, growing at a CAGR of 7.71%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors.

There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals. As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are AMS Biotechnology, Bay Biosciences, Becton, Dickinson and Company, Bioivt & Elevating Science, Boca Biolistics, etc.

Countries Studied

America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)

Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)

Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)

Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Story continues

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Biobanking Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

The analyst analyses the Global Biobanking Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position. Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Why buy this report?

The report offers a comprehensive evaluation of the Global Biobanking Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.

The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.

The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.

The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.

The report also contains the competitive analysis using Positioning Quadrants, the analyst's Proprietary competitive positioning tool.

Key Topics Covered:

1 Report Description

2 Research Methodology

3 Executive Summary

4 Market Dynamics4.1 Drivers4.1.1 Growing Cost-Effective Drug Discovery and Development and 4.1.2 Genomic Research Activities 4.1.3 Advances in Biobanking and Growing Trend of Conserving Cord Blood Stem Cells of Newborns 4.1.4 Government and Private Funding to Support Regenerative Medicine Research4.2 Restraints4.2.1 High Cost of Automation4.2.2 Issues Related to Biospecimen Sample Procurement4.3 Opportunities4.3.1 Emerging Countries 4.3.2 Growing Focus on the R&D of Cell Therapies4.4 Challenges4.4.1 Long-Term Sustainability of Biobanks

5 Market Analysis5.1 Regulatory Scenario5.2 Porter's Five Forces Analysis5.3 Impact of COVID-195.4 Ansoff Matrix Analysis

6 Global Biobanking Market, By Product & Service6.1 Introduction6.2 Equipment6.2.1 Storage Equipment6.2.2 Sample Analysis Equipment6.2.3 Sample Processing Equipment6.2.4 Sample Transport Equipment6.3 Consumables6.3.1 Storage Consumables6.3.2 Analysis Consumables6.3.3 Processing Consumables6.3.4 Collection Consumables6.4 Services6.4.1 Storage Services6.4.2 Processing Services6.4.3 Transport Services6.4.4 Supply Services

7 Global Biobanking Market, By Sample7.1 Introduction7.2 Blood Products7.3 Human Tissues7.4 Cell Lines7.5 Nucleic Acids7.6 Biological Fluids7.7 Human Waste Products

8 Global Biobanking Market, By Storage8.1 Introduction8.2 Manual Storage8.3 Automated Storage

9 Global Biobanking Market, By Application9.1 Introduction9.2 Regenerative Medicine 9.3 Life Science Research 9.4 Clinical Research

10 Americas Biobanking Market10.1 Introduction10.2 Argentina10.3 Brazil10.4 Canada10.5 Chile10.6 Colombia10.7 Mexico10.8 Peru10.9 United States10.10 Rest of Americas

11 Europe's Biobanking Market11.1 Introduction11.2 Austria11.3 Belgium11.4 Denmark11.5 Finland11.6 France11.7 Germany11.8 Italy11.9 Netherlands11.10 Norway11.11 Poland11.12 Russia11.13 Spain11.14 Sweden11.15 Switzerland11.16 United Kingdom11.17 Rest of Europe

12 Middle East and Africa's Biobanking Market12.1 Introduction12.2 Egypt12.3 Israel12.4 Qatar12.5 Saudi Arabia12.6 South Africa12.7 United Arab Emirates12.8 Rest of MEA

13 APAC's Biobanking Market13.1 Introduction13.2 Australia13.3 Bangladesh13.4 China13.5 India13.6 Indonesia13.7 Japan13.8 Malaysia13.9 Philippines13.10 Singapore13.11 South Korea13.12 Sri Lanka13.13 Thailand13.14 Taiwan13.15 Rest of Asia-Pacific

14 Competitive Landscape14.1 Competitive Quadrant14.2 Market Share Analysis14.3 Strategic Initiatives14.3.1 M&A and Investments14.3.2 Partnerships and Collaborations14.3.3 Product Developments and Improvements

15 Company Profiles15.1 AMS Biotechnology15.2 Bay Biosciences15.3 Becton, Dickinson and Company 15.4 Bioivt & Elevating Science15.5 Boca Biolistics15.6 CTI Biotech15.7 Cureline15.8 Cureline15.9 Firalis 15.10 Geneticist 15.11 Greiner Holding AG 15.12 Hamilton Company 15.13 Merck KGaA 15.14 Panasonic Healthcare Holdings 15.15 Promega 15.16 Proteogenex15.17 Qiagen N.V. 15.18 Tecan Trading 15.19 Thermo Fisher Scientific 15.20 US Biolab Corp15.21 VWR International

16 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/wsjf7c

Attachment

Read more:
The Worldwide Biobanking Industry is Expected to Reach $3.6 Billion by 2027 - Yahoo Finance